Prevalence of Poor Performance Status in Lung Cancer Patients: Implications for Research

The prevalence of poor PS is quite high in lung cancer patients. Providers tend to underestimate poor PS. Specific clinical trials and treatment guidelines for this patient population are urgently needed.